Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LLY vs MRNA✓SelectedUSD · MRNALLY vs MRNA performance historyLatest closeAs of-2.29%11/19
Stock and ETF performance explorer

LLY vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+130.7%
MRNA return
+159.5%
Excess return
-28.9%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.3%+1.3%-3.6%-2.3%
7D-5.2%-13.8%+8.6%-4.6%
30D+5.4%-17.7%+23.0%+6.1%
3M+5.7%+14.3%-8.7%+4.6%
6M+32.6%+336.0%-303.3%+19.2%
YTD+26.5%+575.9%-549.4%+9.6%
1Y+29.5%+724.4%-694.9%+10.5%
All+130.7%+159.5%-28.9%+99.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling